Cargando…
In Vivo Antiviral Effects of U18666A Against Type I Feline Infectious Peritonitis Virus
Background: The cationic amphiphilic drug U18666A inhibits the proliferation of type I FIPV in vitro. In this study, we evaluated the in vivo antiviral effects of U18666A by administering it to SPF cats challenged with type I FIPV. Methods: Ten SPF cats were randomly assigned to two experimental gro...
Autores principales: | Doki, Tomoyoshi, Tarusawa, Tomoyo, Hohdatsu, Tsutomu, Takano, Tomomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169457/ https://www.ncbi.nlm.nih.gov/pubmed/31963705 http://dx.doi.org/10.3390/pathogens9010067 |
Ejemplares similares
-
The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection
por: Takano, Tomomi, et al.
Publicado: (2017) -
Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo
por: Takano, Tomomi, et al.
Publicado: (2013) -
Differential effects of viroporin inhibitors against feline infectious peritonitis virus serotypes I and II
por: Takano, Tomomi, et al.
Publicado: (2015) -
Therapeutic effect of anti-feline TNF-alpha monoclonal antibody for feline infectious peritonitis
por: Doki, Tomoyoshi, et al.
Publicado: (2016) -
Antiviral activity of itraconazole against type I feline coronavirus infection
por: Takano, Tomomi, et al.
Publicado: (2019)